Firms
Theme

DOCS

Doximity, Inc. · NYSE

↓ $0.29 (0.86%)

Last close · Oct 23, 4:00 PM ET

Sign up free to see this.

Mkt Cap
$6B
Volume
1.3M
52W High
$71.37
52W Low
$17.15
PE Ratio
35.6
Avg Vol
3.1M
As of 10/23/26
Div Yield
—
Beta
0.47
As of 10/23/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about DOCS?

Latest news

News ›

GlobeNewswire Inc.

Bragar Eagel & Squire, P.C. Reminds Doximity, Inc. Investors that a Class Action Lawsuit Has Been Filed Against Doximity and Encourages Investors to Contact the Firm Before November 16th

A class action lawsuit has been filed against Doximity, Inc. for allegedly misleading investors about its Newsfeed product being its primary revenue driver. The complaint claims Doximity overstated the Newsfeed's impact on revenue growth, was losing market share to competitors, and relied heavily on banner ads and email newsletters despite denying it. Investors who purchased shares between August 8, 2024, and May 13, 2026, can join the lawsuit with a November 16, 2026 deadline to apply as lead plaintiff.

GlobeNewswire Inc.

Deadline Alert: Doximity, Inc. Investors Have Until November 16, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds

Doximity, Inc. investors have until November 16, 2026 to seek lead plaintiff status in a securities fraud class action lawsuit. The complaint alleges the company made materially false statements and failed to disclose that it overstated its Newsfeed's revenue impact, was losing market share to competitors, and relied on less effective advertising tactics. The stock declined significantly following three earnings announcements between November 2025 and May 2026.

GlobeNewswire Inc.

Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Doximity, Inc. alleging securities fraud. The complaint claims Doximity made false statements about its Newsfeed's revenue impact, overstated market position, and misrepresented advertising practices. Investors who purchased Doximity securities between August 8, 2024 and May 13, 2026 are encouraged to join the case, with a lead plaintiff deadline of November 16, 2026.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $DOCS · 0 threads

Sign in to post on $DOCS

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev